rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2006-3-28
|
pubmed:abstractText |
Botulinum neurotoxins (BoNTs) inhibit neurotransmitter release by selectively cleaving core components of the vesicular fusion machinery. The synaptic vesicle proteins Synaptotagmin-I and -II act as receptors for BoNT/B and BoNT/G. Here we show that BoNT/A also interacts with a synaptic vesicle protein, the synaptic vesicle glycoprotein 2C (SV2C), but not with the homologous proteins SV2A and SV2B. Binding of BoNT/A occurs at the membrane juxtaposed region preceding transmembrane domain 8. A peptide comprising the intravesicular domain between transmembrane domains 7 and 8 specifically reduces the neurotoxicity of BoNT/A at phrenic nerve preparations demonstrating the physiological relevance of this interaction.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0014-5793
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
3
|
pubmed:volume |
580
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2011-4
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:16545378-Animals,
pubmed-meshheading:16545378-Botulinum Toxins, Type A,
pubmed-meshheading:16545378-Membrane Glycoproteins,
pubmed-meshheading:16545378-Mice,
pubmed-meshheading:16545378-Nerve Tissue Proteins,
pubmed-meshheading:16545378-Phrenic Nerve,
pubmed-meshheading:16545378-Protein Binding,
pubmed-meshheading:16545378-Protein Structure, Tertiary,
pubmed-meshheading:16545378-Protein Transport,
pubmed-meshheading:16545378-Recombinant Fusion Proteins
|
pubmed:year |
2006
|
pubmed:articleTitle |
The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves.
|
pubmed:affiliation |
Institute of Biochemistry, OE 4310, Carl-Neuberg-Strasse 1, Medical School Hannover, 30623 Hannover, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|